Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access / Beckers
Ella Jeffries / beckershospitalreview - Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 medications and suppress competition. The lawsuit, filed i…
#obesity #healthcare #pharmaceuticals #drugpricing #elililly #novonordisk #weightloss #publichealth #biotech
Thursday, January 15, 2026, 1:23 pm / permalink 17926 / 4 stories in 7 wks
FDA moves to remove suicide warnings from GLP-1 weight loss drugs / Medical Express
medicalxpress - Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels.
#obesity #healthcare #pharmaceuticals #elililly #novonordisk #weightloss #publichealth #governmentpolicy #fda
Thursday, January 15, 2026, 1:23 pm / permalink 17924 / 8 stories in 7 wks